Fertility and Endometriosis

Fertility and Endometriosis — scientific infographic poster

Table of Contents

  1. The Fertility Impact — The Real Numbers
  2. How Endo Gets Between You and Pregnancy
  3. Endometriomas and Ovarian Reserve
  4. ASRM Stages I–IV and Fertility
  5. Typical Referral Points for a Reproductive Endocrinologist
  6. The Fertility Workup
  7. Excision Before IVF — The Debate
  8. IVF Protocols for Endometriosis
  9. Egg Freezing — Who It Is Discussed For
  10. Natural Conception After Excision
  11. Ovarian Reserve Monitoring
  12. Adenomyosis and Fertility
  13. Pregnancy With Endometriosis
  14. Breastfeeding and Endo
  15. The Emotional Journey
  16. Alternative Paths to Parenthood
  17. Key Research Papers
  18. Connections
  19. Featured Videos

The Fertility Impact — The Real Numbers

If you have endometriosis and you are trying to conceive, the first thing to know is that your odds are not zero — but they are not the odds the fertility posters at your OB's office advertise. Somewhere between 30% and 50% of people with endometriosis experience subfertility, compared with roughly 10–15% of the general reproductive-age population. That means your chance of needing medical help to conceive is roughly three to five times higher than the friend sitting next to you who does not have this disease.

The number is a range rather than a single figure because endometriosis itself is a range. Stage I disease in someone with otherwise normal anatomy might have almost no fertility impact. Stage IV disease with frozen pelvis, bilateral endometriomas, and deep bowel involvement can effectively close the natural-conception door. The honest answer to "will I need IVF?" is usually "we don't know yet, and most of the variables are within your control only partially."

The good news buried in the statistics: most people with endometriosis who want a biological child will eventually have one, even if the route is longer, more expensive, and more emotionally punishing than they expected. What follows is a map of that route.

How Endo Gets Between You and Pregnancy

Endometriosis interferes with fertility through at least four distinct mechanisms, often layered on top of one another in the same person.

Mechanical distortion. Endometriosis lesions cause fibrotic adhesions — bands of scar tissue that glue pelvic organs together. Fallopian tubes get kinked, pulled, or sealed shut. Ovaries become tethered to the pelvic sidewall or the back of the uterus. The delicate choreography of ovulation, tubal pickup, and fertilization depends on free-floating, mobile anatomy. A pelvis with extensive adhesions simply cannot perform the mechanical work of conception, no matter how healthy the eggs and sperm are.

Inflammatory environment. Endo lesions pump out prostaglandins, cytokines (interleukin-1, interleukin-6 (IL-6), tumor necrosis factor-alpha), and reactive oxygen species that flood the peritoneal fluid. This inflammatory soup is toxic to eggs, sperm, and early embryos. Studies show reduced sperm motility in endometriotic peritoneal fluid, impaired fertilization rates even in IVF dishes, and lower egg quality retrieved from affected ovaries.

Endometrial receptivity changes. Even when an embryo reaches the uterine cavity, the uterine lining in endometriosis often does not respond normally to progesterone. Researchers call this progesterone resistance. Key implantation genes fail to switch on in the expected pattern, and the "implantation window" — the five or six days each cycle when the endometrium is receptive — narrows or shifts.

Ovarian reserve reduction. This is the mechanism most patients do not hear about until they are already in a fertility clinic. Endometriomas — ovarian cysts filled with old blood — damage the ovarian cortex around them, killing off resting follicles. Surgery on endometriomas can remove even more. The result is a smaller starting egg pool at every age.

Endometriomas and Ovarian Reserve

An endometrioma (often called a "chocolate cyst" for its dark old-blood contents) is an endometriosis lesion that has invaded an ovary and built a cyst cavity inside it. On ultrasound they have a classic ground-glass appearance. They are common — roughly 17–44% of people with endometriosis have at least one.

Endometriomas matter for fertility in two ways. First, their mere presence lowers ovarian reserve. Multiple studies show that ovaries with endometriomas have lower anti-Müllerian hormone (AMH), lower antral follicle counts (AFC), and yield fewer mature eggs per IVF retrieval compared with the contralateral unaffected ovary in the same patient. The inflammatory cyst environment appears to accelerate loss of primordial follicles.

Second, surgery on endometriomas drops reserve further. The standard excision technique — cystectomy, where the cyst wall is stripped away from the ovarian tissue — inevitably removes healthy follicles trapped in or adjacent to the cyst capsule. Post-operative AMH typically falls by 25–50% after unilateral cystectomy and even more sharply after bilateral surgery. A 2012 systematic review found a significant drop in AMH after endometrioma surgery in 9 of 11 studies, with a larger decline after surgery on both ovaries. A 2012 pooled analysis of 8 studies (237 women) found that AMH fell by an average of 1.13 ng/mL after endometrioma cystectomy, and by 1.52 ng/mL in women who started with normal-to-high levels (3.1 ng/mL or more) — the clearest measure of the egg-reserve loss described here. For someone already in their late thirties or with borderline reserve, a bilateral endometrioma stripping can be fertility-ending.

This single fact drives most of the modern controversy about endometriosis management in people who want children. You cannot undo a cystectomy.

ASRM Stages I–IV and Fertility

The American Society for Reproductive Medicine staging system assigns points based on lesion depth, location, and adhesions:

A hard-earned lesson in the field: the ASRM score predicts pain and surgical complexity better than it predicts fertility. Plenty of stage I patients have unexplained subfertility. Plenty of stage IV patients conceive on the first IVF cycle once the right protocol is used. The stage works as a rough planning tool, not a verdict.

Typical Referral Points for a Reproductive Endocrinologist

The standard infertility thresholds for seeing a reproductive endocrinologist (REI) shift earlier when endometriosis is in the picture. The commonly used referral points:

An REI is a gynecologist with three additional years of fellowship training in fertility, which is why this workup usually sits with an REI rather than a general OB-GYN.

The Fertility Workup

The first two or three REI visits typically include:

If an endometrioma is present on ultrasound, the REI typically measures it, note which ovary, and factor it into the plan — not always by removing it.

Excision Before IVF — The Debate

This is the single most-argued question in endometriosis fertility care. There is no one right answer.

The case for excision first:

The case against excision first:

What the ESHRE 2022 guideline says: clinicians are not recommended to routinely operate before assisted reproduction (ART) in stage I/II disease, because the potential benefits are unclear, or on an ovarian endometrioma, "as the current evidence shows no benefit and surgery is likely to have a negative impact on ovarian reserve". Surgery for an endometrioma before ART "can be considered to improve endometriosis-associated pain or accessibility of follicles", and the decision to remove deep endometriosis before ART is to be "guided mainly by pain symptoms and patient preference as its effectiveness on reproductive outcome is uncertain". Going directly to IVF is common when the disease is superficial, reserve is already low, age is pressing, or the pain is tolerable and the shortest path to a pregnancy is the priority.

Many patients seek opinions from both a skilled excision surgeon and an REI before deciding. They often disagree, and the tension between their views is useful information.

IVF Protocols for Endometriosis

Not every IVF cycle looks the same, and endometriosis patients often need a tailored approach.

Ultra-long GnRH agonist protocol. A long-studied endo-specific protocol. The patient receives a GnRH agonist (such as leuprolide) for 3 to 6 months before ovarian stimulation. This prolonged suppression shrinks active disease, calms inflammation, and allows the endometrium to reset. A 2006 Cochrane review (Sallam; 3 trials, 165 women) found the odds of clinical pregnancy about four times higher (odds ratio 4.28) with 3–6 months of GnRH agonist before IVF compared with no pretreatment. Its 2019 update (Georgiou; 8 trials, 640 women, very low-quality evidence) did not confirm this: "contrary to previous findings", the reviewers were uncertain whether the treatment changes live birth or clinical pregnancy rates (clinical pregnancy risk ratio 1.13, 95% CI 0.91–1.41). The 2022 ESHRE guideline states that extended GnRH agonist treatment before ART to improve live birth rate "is not recommended, as the benefit is uncertain" (a strong recommendation). The cost is real: three to six months of menopausal-like symptoms before you even start stims.

GnRH antagonist protocol. The shorter, modern standard. Stimulation starts on cycle day 2–3; an antagonist (cetrorelix, ganirelix) is added mid-cycle to prevent premature ovulation. Less suppression, faster, cheaper, and adequate for many endo patients — particularly those with mild disease or diminished reserve who cannot afford the time cost of a long protocol.

Letrozole-primed stimulation. For patients with low reserve or estrogen-sensitive disease, letrozole (an aromatase inhibitor) added during stim keeps estradiol levels lower, potentially reducing endo flare. Useful in oncofertility overlap and in patients who get severe pain with high estrogen.

DuoStim (double stimulation). Two egg retrievals in the same menstrual cycle — one follicular, one luteal. Built for patients with very low reserve who need to bank as many eggs or embryos as possible as quickly as possible. Endometriosis patients with rapidly declining AMH are candidates.

Frozen embryo transfer with endometrial preparation. Many clinics now separate retrieval from transfer for endo patients: retrieve embryos, freeze them, then do a medicated or natural transfer cycle later when the endometrium is calmer. Transfer outcomes in endo often improve with this approach, sometimes combined with a short course of pre-transfer GnRH agonist suppression.

Egg Freezing — Who It Is Discussed For

Egg freezing is the single most underused tool in endometriosis care. It is most often discussed for people who:

A freezing cycle is biologically identical to the first half of an IVF cycle: stimulation, retrieval, vitrification of mature oocytes. U.S. costs typically run $12,000–$20,000 per cycle plus $500–$1,000 per year of storage. Some employers now cover it. Frozen eggs have no expiration date, and survival thaw rates at modern labs exceed 90%.

The 2022 ESHRE guideline states that with extensive ovarian endometriosis, clinicians discuss the pros and cons of fertility preservation with the woman, and that "the true benefit of fertility preservation in women with endometriosis remains unknown".

Natural Conception After Excision

For patients with moderate-to-severe disease, complete excision by a high-volume surgeon restores spontaneous conception in a meaningful share of cases: roughly 40–60% conceive within 12 months of full excision, with the highest rates in younger patients with normal reserve. Outcomes drop sharply after age 38 and after repeat surgery.

The practical implication: if excision is planned and you want a biological child, the 6–12 month window after surgery is your best spontaneous-conception window. Disease recurs over time; so does adhesion formation. Most excision surgeons advise not delaying attempts.

Ovarian Reserve Monitoring

For people with endometriosis who want to keep their options open, serial AMH testing every 6–12 months is one way to follow ovarian reserve over time. AMH trajectories matter as much as the absolute number. A sharp drop — even from a "normal" value into the lower-normal range — is commonly read as a signal to move plans forward.

Before planned ovarian surgery, AMH and AFC are commonly measured, and fertility preservation can be raised explicitly with the surgeon. "I may want to freeze eggs before this cystectomy" is a legitimate request that can pause the surgical calendar.

Adenomyosis and Fertility

Adenomyosis — endometrial tissue within the uterine muscle — commonly coexists with endometriosis and has its own independent fertility impact. It reduces implantation rates, increases miscarriage risk, and is associated with worse IVF outcomes. The same ultra-long GnRH agonist suppression is also used for adenomyosis before IVF transfer, with several studies showing implantation rates climbing by 10–15 percentage points after 2–3 months of pre-transfer suppression.

If your magnetic resonance imaging (MRI) or ultrasound shows adenomyosis features — diffuse myometrial thickening, junctional zone changes, cystic spaces — it is relevant to the IVF plan alongside the endometriosis.

Pregnancy With Endometriosis

One persistent myth deserves a direct contradiction: pregnancy does not cure endometriosis. Many patients experience a temporary reprieve from pain during the pregnancy itself (thanks to the high, steady progesterone state), but the disease returns — often within a few months of delivery or after breastfeeding ends.

Pregnancy with endo also carries real obstetric risks:

A 2018 meta-analysis of 33 observational studies put numbers on these risks: compared with women without endometriosis, women with endometriosis had higher odds of placenta previa (odds ratio 3.31), preterm birth (1.70), caesarean section (1.86), stillbirth (1.29), small-for-gestational-age babies (1.28) and pre-eclampsia (1.18).

Most of these risks are managed by co-management with a maternal-fetal medicine specialist, and the endometriosis history is relevant to the obstetric team from the first prenatal visit.

Breastfeeding and Endo

Exclusive breastfeeding often suppresses ovulation for months, and the associated lactational amenorrhea is frequently a pain-free window for endo patients. Many patients describe the postpartum breastfeeding phase as the most comfortable stretch they have had since menarche.

When menstrual cycles resume, symptoms typically resume with them. This is not a failure of breastfeeding or a sign that something new has happened — it is the disease coming back online with your hormones. Knowing this ahead of time means it need not come as a surprise.

The Emotional Journey

No amount of protocol detail captures what it feels like to try to build a family against this disease. Month after month of negative tests. Procedures scheduled around work. Injections in a car before a meeting. Marriages that strain and sometimes crack. Friendships that quietly thin because you cannot stand another baby shower. Financial decisions that would look insane on paper if you were not desperate.

Grief belongs here. The grief of a body that will not cooperate. The grief of a timeline rewritten without your consent. The grief, often, of watching someone younger and healthier conceive on the first try while your third IVF fails. These feelings are not weakness; they are the appropriate response to accumulated loss.

Practical supports people describe as helpful: a therapist who specializes in reproductive grief, a peer group (Resolve, local endo groups, online communities), honest conversations with your partner about what you can and cannot sustain, and written limits — how many cycles, how much money, how long — agreed on in calm moments and revisited before each decision. Guardrails protect you from the sunk-cost spiral that fertility treatment can become.

Alternative Paths to Parenthood

IVF is not the only path, and it is not always the right one. All of the following are legitimate, full forms of parenthood:

Whichever road you take, it is yours. Endometriosis may narrow the options, but it does not get to choose for you.

Key Research Papers

  1. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;(1):CD004635. — doi:10.1002/14651858.CD004635.pub2
  2. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531-1538. — doi:10.1016/j.fertnstert.2012.08.009
  3. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-275. — doi:10.1038/nrendo.2013.255
  4. Becker CM, Bokor A, Heikinheimo O, et al; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. — doi:10.1093/hropen/hoac009
  5. Georgiou EX, Melo P, Baker PE, Sallam HN, Arici A, Garcia-Velasco JA, Abou-Setta AM, Becker C, Granne IE. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database Syst Rev. 2019;2019(11):CD013240. — doi:10.1002/14651858.CD013240.pub2
  6. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146-3154. — doi:10.1210/jc.2012-1558
  7. Lalani S, Choudhry AJ, Firth B, Bacal V, Walker M, Wen SW, Singh S, Amath A, Hodge M, Chen I. Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis. Hum Reprod. 2018;33(10):1854-1865. — doi:10.1093/humrep/dey269

PubMed Topic Searches

For further reading, the following PubMed topic searches return current peer-reviewed work on endometriosis and fertility:

  1. PubMed: Endometriosis and IVF outcomes
  2. PubMed: Ultra-long GnRH agonist protocol in endometriosis IVF
  3. PubMed: Endometrioma and ovarian reserve (AMH)
  4. PubMed: Endometrioma cystectomy and fertility outcomes
  5. PubMed: Deep-infiltrating endometriosis and fertility
  6. PubMed: Adenomyosis and IVF outcomes
  7. PubMed: Endometriosis and pregnancy complications
  8. PubMed: Endometriosis, progesterone resistance, and implantation

Back to Table of Contents

Connections

Back to Table of Contents